1 Nicolaides KH.Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.Am J Obstet Gynecol,2004,191:45-67. 2 Nicolaides KH,Heath V,Cicero S.Increased fetal nuchal translucency at 11-14 weeks.Prenat Diagn,2002,22:308-315. 3 赵欣荣,王彦林,范阳阳,等.胎儿颈项透明层增厚的临床咨询及预后分析.上海交通大学学报(医学版),2018,38:529-532. 4 郑文婷,尹志军,梁映亮,等.198例颈部透明层增厚胎儿的染色体核型分析.中国优生与遗传杂志,2017,25:54-55,83. 5 王游声,张亿聪,张琪,等.胎儿颈项透明层增厚的产前诊断结果分析.中华医学遗传学杂志,2022,39:248-250. 6 Snijders RJ,Noble P,Sebire N,et al.UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.Fetal Medicine Foundation First Trimester Screening Group.Lancet,1998,352:343-346. 7 Sharifzadeh M,Adibi A,Kazemi K,et al.Normal reference range of fetal nuchal translucency thickness in pregnant women in the first trimester,one center study.J Res Med Sci,2015,20:969-973. 8 Lichtenbelt KD,Diemel BD,Koster MP,et al.Detection of fetal chromosomal anomalies:does nuchal translucency measurement have added value in the era of non-invasive prenatal testing.Prenat Diagn,2015,35:663-668. 9 郑烨,勇强,张蕾,等.胎儿颈项透明层测值与妊娠不良结局的相关性分析.中国超声医学杂志,2019,35:43-45. 10 王桂民,刘晓英,张辉.早期超声检测胎儿颈项透明层厚度在胎儿心脏畸形及染色体异常诊断中的应用及相关性.中国优生与遗传杂志,2019,27:870-872. 11 Shamshirsaz AA,Salmanian B,Ravangard SF,et al.Nuchal translucency and cardiac abnormalities in euploid singleton pregnancies.J Matern Fetal Neonatal Med,2014,27:495-499. 12 罗彩群,刘洋,郝颖,等.339例核型正常的颈项透明层增厚胎儿的染色体微阵列分析.中华围产医学杂志,2019,22:581-586. 13 杨鑫,符芳,李茹,等.染色体微阵列分析在核型正常的颈项透明层增厚胎儿中的应用.中华医学遗传学杂志,2015,32:370-374. 14 Cicatiello R,Pignataro P,Izzo A,et al.Chromosomal microarray analysis versus karyotyping in fetuses with increased nuchal translucency.Med Sci(Basel),2019,7. 15 Baken L,Benoit B,Koning A,et al.First-trimester crown-rump length and embryonic volume of fetuses with structural congenital abnormalities measured in virtual reality:An observational study.Biomed Res Int,2017,2017:1953076. 16 Spaggiari E,Czerkiewicz I,Sault C,et al.Impact of including or removing nuchal translucency measurement on the detection and false-positive rates of first-trimester down syndrome screening.Fetal Diagn Ther,2016,40:214-218.
